Login
Toggle navigation
Videos
Categories
Trending
Elias Papatheodorou, CEO of Genkyotex, tells us more about his relationship with the BioDiscovery team
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
BioDiscovery by Elias Papatheodorou, CEO of Genkyotex
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Recover Funds from Gorks Bit Scam with MFG Service Inc.
00:10:00
Prairie Creek Project: High-Grade Zinc and Lead Mine Restart in Northwest Territories, Canada
00:10:00
Mastering Markets: Toby Crabel on Counter-Trend Trading Strategies and Price Action | Toby Crabel – Commodities Trader, Crabel Capital Management
00:10:00
Jaxon explores for deep-seated porphyry epithermal systems in the Hazelton region, seeking industry partners to accelerate project advancement. |JOHN KING BURNS Chairman & Chief Executive Officer of Jaxon Mining Inc.
00:10:00
Jeffrey Lipson, president and CEO of HASI, joins 'The Exchange' to discuss the company's financial strategies and sustainability focus.
00:10:00
Retirement Planning with Michael Kitces | Michael Kitces - Renowned Financial Planner and Educator
00:10:00
Cesar Gon, CEO of CI&T, says 'We are living through a technological revolution' in O Globo.
00:10:00
Investments in SaaS and infrastructure software startups|David Heller,General Partner,Vertex Ventures
00:10:00
Elevate Uranium Sets Stage for Breakthrough with Low-Cost, High-Grade Processing in Namibia|Murray Hill,CEO,Elevate Uranium
00:10:00
Polymetals Resources Extends Alahiné Phase 2 Drilling with Cost-Efficient Strategy | Mr. Alex Hanly, CEO , Polymetals Resources Ltd.
00:10:00
Orezone's Ongoing Success and Expansion at the Odienne Gold Project
00:10:00
William Dawes Discusses Mkango's Rare Earths Project at One-to-One Conference